BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21907910)

  • 1. Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors.
    Hudson BD; Smith NJ; Milligan G
    Adv Pharmacol; 2011; 62():175-218. PubMed ID: 21907910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    DeWire SM; Violin JD
    Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology and therapeutics of the free fatty acid receptor GPR40.
    Huang H; Dai MH; Tao YX
    Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets.
    Milligan G; Ulven T; Murdoch H; Hudson BD
    Br J Nutr; 2014 Jun; 111 Suppl 1():S3-7. PubMed ID: 24382058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptors for free fatty acids.
    Milligan G; Stoddart LA; Brown AJ
    Cell Signal; 2006 Sep; 18(9):1360-5. PubMed ID: 16716567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphan G protein-coupled receptors: from DNA to drug targets.
    Shaaban S; Benton B
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):535-47. PubMed ID: 12825450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex Pharmacology of Free Fatty Acid Receptors.
    Milligan G; Shimpukade B; Ulven T; Hudson BD
    Chem Rev; 2017 Jan; 117(1):67-110. PubMed ID: 27299848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
    Prinster SC; Hague C; Hall RA
    Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
    Suga H; Haga T
    Neurochem Int; 2007; 51(2-4):140-64. PubMed ID: 17659814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands.
    Kostenis E
    Pharmacol Ther; 2004 Jun; 102(3):243-57. PubMed ID: 15246248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
    Colette J; Avé E; Grenier-Boley B; Coquel AS; Lesellier K; Puget K
    J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of ligands at orphan G-protein coupled receptors.
    Wise A; Jupe SC; Rees S
    Annu Rev Pharmacol Toxicol; 2004; 44():43-66. PubMed ID: 14744238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes.
    Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GPCRs heterodimerization: a new way towards the discovery of function for the orphan receptors?].
    Levoye A; Jockers R
    Med Sci (Paris); 2007; 23(8-9):746-50. PubMed ID: 17875294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.